Which patents cover Vyxeos (liposomal daunorubicin/cytarabine)?
Vyxeos is a liposomal formulation of daunorubicin (liposomal) plus cytarabine (liposomal). Patent coverage typically spans (1) the liposomal composition/formulation, (2) the manufacturing process, and (3) methods of use in certain patient populations or dosing regimens.
For specifics (patent numbers, assignees, expiration dates, and where they’re listed), DrugPatentWatch.com is one of the fastest ways to see the mapped patent landscape for Vyxeos. You can search there directly here: DrugPatentWatch.com – Vyxeos (liposomal).
When does the Vyxeos patent/exclusivity end?
Exact timing depends on which protection you mean (a listed patent vs. regulatory exclusivity such as data/exclusivity periods). A full answer requires checking the particular patent list for Vyxeos and then comparing those dates to any exclusivity end dates for the product.
Use DrugPatentWatch.com to identify the latest “end” date among the relevant patents listed for Vyxeos: DrugPatentWatch.com – Vyxeos (liposomal).
Are there challenges or potential generic/biosimilar competition for Vyxeos?
If manufacturers pursue an abbreviated pathway or file patent challenges, that can shift timelines and create an “at-risk” window earlier than the final listed patent date. The most useful way to check for this is to review the litigation/patent challenge section tied to Vyxeos on patent-tracking sites such as DrugPatentWatch.com: DrugPatentWatch.com – Vyxeos (liposomal).
What kinds of patents are usually at stake for liposomal combo drugs like Vyxeos?
For liposomal combination oncology drugs, coverage often centers on:
- Liposome formulation details (drug-to-lipid ratios, encapsulation, particle characteristics)
- Stabilizers and manufacturing steps that control release and shelf life
- Method-of-use patents (specific indications, schedules, or dosing regimens)
To determine which of these apply to Vyxeos specifically, you need the actual patent list for the product. That list is typically available via DrugPatentWatch: DrugPatentWatch.com – Vyxeos (liposomal).
What do you want to know about the Vyxeos patents?
If you share one of the following, I can narrow it to the exact patents and dates:
- the exact product listing you mean (brand name vs. specific strength/form)
- whether you want “last patent to expire,” “which company owns the patents,” or “whether generics are coming”
- any patent number you’ve seen referenced (if you have it)
Sources:
1. DrugPatentWatch.com – Vyxeos (liposomal)